25.02.2016 11:19:31
|
DGAP-Kapitalmarktinformation: B.R.A.I.N. Biotechnology Research and Information Network AG
DGAP-CMS: B.R.A.I.N. Biotechnology Research And Information Network AG: Release of the Home Member State according to Article 2c of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
--------------------------------------------------------------------------- Language: English Company: B.R.A.I.N. Biotechnology Research And Information Network AG Darmstädter Straße 34-36 64673 Zwingenberg Germany Internet: www.brain-biotech.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
B.R.A.I.N. Biotechnology Research And Information Network AG / Home Member State
25.02.2016 11:19
Dissemination of a Post-admission Duties announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
B.R.A.I.N. Biotechnology Research And Information Network AG announces
according to Art. 2c WpHG that Germany is the Home Member State.
25.02.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
--------------------------------------------------------------------------- Language: English Company: B.R.A.I.N. Biotechnology Research And Information Network AG Darmstädter Straße 34-36 64673 Zwingenberg Germany Internet: www.brain-biotech.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BRAIN Biotech AGmehr Nachrichten
Analysen zu BRAIN Biotech AGmehr Analysen
Aktien in diesem Artikel
BRAIN Biotech AG | 2,57 | 2,80% |
|